{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:30:55Z","timestamp":1780097455338,"version":"3.54.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T00:00:00Z","timestamp":1725667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T00:00:00Z","timestamp":1725667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008793","name":"Universidad del Rosario","doi-asserted-by":"publisher","award":["ABN011"],"award-info":[{"award-number":["ABN011"]}],"id":[{"id":"10.13039\/501100008793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008793","name":"Universidad del Rosario","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008793","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To evaluate the performance of the Systemic Lupus Erythematosus Risk Probability Index (SLERPI) in Colombian patients with systemic lupus erythematosus (SLE).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The Colombian cohort included 435 SLE patients and 430 controls with other autoimmune diseases (ADs). Clinical and serological data were collected, and SLE was indicated by SLERPI scores\u2009&gt;\u20097. The American College of Rheumatology (ACR)-1997, Systemic Lupus International Collaborating Clinics (SLICC)-2012, and European League Against Rheumatism (EULAR)\/ACR-2019 criteria were used as reference standards. The impact of overt polyautoimmunity (PolyA) on SLERPI performance was assessed. Additionally, multivariate lineal regression analysis was performed to evaluate the contribution of SLERPI features to the overall SLERPI score.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>SLE patients had higher SLERPI scores (P\u2009&lt;\u20090.0001), with almost 90% meeting \"definite\" lupus criteria. Main factors influencing SLERPI included immunological disorder (\u03b2:44.75, P\u2009&lt;\u20090.0001), malar\/maculopapular rash (\u03b2:18.43, P\u2009&lt;\u20090.0001), and anti-nuclear antibody positivity (\u03b2:15.65, P\u2009&lt;\u20090.0001). In contrast, subacute cutaneous lupus erythematosus\/discoid lupus erythematosus (\u03b2:2.40, P\u2009&gt;\u20090.05) and interstitial lung disease (\u03b2:-21.58, P\u2009&gt;\u20090.05) were not significant factors to the overall SLERPI score. SLERPI demonstrated high sensitivity for SLE, both for the overall SLE group and for those without overt PolyA (95.4% and 94.6%, respectively), but had relatively low specificity (92.8% and 93.7%, respectively). The model showed high sensitivity for hematological lupus (98.8%) and lupus nephritis (96.0%), but low sensitivity for neuropsychiatric lupus (93.2%). Compared to the ACR-1997, SLICC-2012 and EULAR\/ACR-2019 criteria, SLERPI yielded the highest sensitivity and lowest specificity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>SLERPI efficiently identified SLE patients in a Colombian cohort, showing high sensitivity but low specificity. The model effectively distinguishes SLE patients, even in the presence of concurrent overt PolyA.<\/jats:p>\n                <jats:p><jats:table-wrap><jats:table><jats:tbody>\n                      <jats:tr>\n                        <jats:td align=\"left\" colspan=\"2\"><jats:bold>Key Points<\/jats:bold>\u2022<jats:italic>SLERPI has a high sensitivity, but low specificity compared to ACR-1997, SLICC-2012 and EULAR\/ACR-2019 criteria in the Colombian population.<\/jats:italic>\u2022<jats:italic>Within the SLERPI score, immunological disorder, malar\/maculopapular rash, and anti-nuclear antibody positivity are the strongest predictors of SLE.<\/jats:italic>\u2022<jats:italic>SLERPI model can efficiently distinguish patients with SLE, regardless of concomitant overt PolyA.<\/jats:italic>\u2022<jats:italic>SLERPI demonstrates high sensitivity in identifying hematological and nephritic subphenotypes of SLE.<\/jats:italic><\/jats:td>\n                      <\/jats:tr>\n                    <\/jats:tbody><\/jats:table><\/jats:table-wrap><\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10067-024-07108-x","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T07:02:03Z","timestamp":1725692523000},"page":"3313-3322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Performance of the Systemic Lupus Erythematosus Risk Probability Index (SLERPI) in a cohort of Colombian population"],"prefix":"10.1007","volume":"43","author":[{"given":"Mariana","family":"Celis-Andrade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yhojan","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Benjam\u00edn","family":"Calderon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Rodr\u00edguez-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Monsalve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeny","family":"Acosta-Ampudia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2137-4899","authenticated-orcid":false,"given":"Carolina","family":"Ram\u00edrez-Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,7]]},"reference":[{"key":"7108_CR1","doi-asserted-by":"publisher","first-page":"v4","DOI":"10.1093\/rheumatology\/keaa379","volume":"59","author":"M Aringer","year":"2020","unstructured":"Aringer M, Johnson SR (2020) Classifying and diagnosing systemic lupus erythematosus in the 21st century. Rheumatology 59:v4\u2013v11. https:\/\/doi.org\/10.1093\/rheumatology\/keaa379","journal-title":"Rheumatology"},{"key":"7108_CR2","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725. https:\/\/doi.org\/10.1002\/art.1780400928","journal-title":"Arthritis Rheum"},{"key":"7108_CR3","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai A-M, Alarc\u00f3n GS et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677\u20132686. https:\/\/doi.org\/10.1002\/art.34473","journal-title":"Arthritis Rheum"},{"key":"7108_CR4","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.semarthrit.2019.09.009","volume":"49","author":"M Aringer","year":"2019","unstructured":"Aringer M (2019) EULAR\/ACR classification criteria for SLE. Semin Arthritis Rheum 49:S14\u2013S17. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.09.009","journal-title":"Semin Arthritis Rheum"},{"key":"7108_CR5","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1136\/annrheumdis-2020-219069","volume":"80","author":"C Adamichou","year":"2021","unstructured":"Adamichou C, Genitsaridi I, Nikolopoulos D et al (2021) Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus. Ann Rheum Dis 80:758\u2013766. https:\/\/doi.org\/10.1136\/annrheumdis-2020-219069","journal-title":"Ann Rheum Dis"},{"key":"7108_CR6","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1093\/rheumatology\/keac120","volume":"61","author":"BCH Tan","year":"2022","unstructured":"Tan BCH, Tang I, Bonin J et al (2022) The performance of different classification criteria for systemic lupus erythematosus in a real-world rheumatology department. Rheumatology (Oxford) 61:4509\u20134513. https:\/\/doi.org\/10.1093\/rheumatology\/keac120","journal-title":"Rheumatology (Oxford)"},{"key":"7108_CR7","doi-asserted-by":"publisher","unstructured":"Zhang L, Lu W, Yan D et al (2023) Systemic Lupus Erythematosus Risk Probability Index: ready for routine use? Results from a Chinese cohort. Lupus Sci Med 10:. https:\/\/doi.org\/10.1136\/lupus-2023-000988","DOI":"10.1136\/lupus-2023-000988"},{"key":"7108_CR8","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1177\/09612033241238053","volume":"33","author":"JP Casta\u00f1eda-Gonz\u00e1lez","year":"2024","unstructured":"Casta\u00f1eda-Gonz\u00e1lez JP, Mogoll\u00f3n Hurtado SA, Rojas-Villarraga A et al (2024) Comparison of the SLE Risk Probability Index (SLERPI) scale against the European League Against Rheumatism\/American College of Rheumatology (ACR\/EULAR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria. Lupus 33:520\u2013524. https:\/\/doi.org\/10.1177\/09612033241238053","journal-title":"Lupus"},{"key":"7108_CR9","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jbspin.2017.12.012","volume":"85","author":"M Rojas","year":"2018","unstructured":"Rojas M, Rodriguez Y, Pacheco Y et al (2018) Resilience in women with autoimmune rheumatic diseases. Jt Bone Spine 85:715\u2013720. https:\/\/doi.org\/10.1016\/j.jbspin.2017.12.012","journal-title":"Jt Bone Spine"},{"key":"7108_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1136\/annrheumdis-2017-212285","volume":"77","author":"E Papadaki","year":"2018","unstructured":"Papadaki E, Fanouriakis A, Kavroulakis E et al (2018) Neuropsychiatric lupus or not? Cerebral hypoperfusion by perfusion-weighted MRI in normal-appearing white matter in primary neuropsychiatric lupus erythematosus. Ann Rheum Dis 77:441\u2013448. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212285","journal-title":"Ann Rheum Dis"},{"key":"7108_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/aca.ACA_157_18","volume":"22","author":"P Mishra","year":"2019","unstructured":"Mishra P, Pandey CM, Singh U et al (2019) Descriptive statistics and normality tests for statistical data. Ann Card Anaesth 22:67\u201372. https:\/\/doi.org\/10.4103\/aca.ACA_157_18","journal-title":"Ann Card Anaesth"},{"key":"7108_CR12","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/acr.22583","volume":"67","author":"R Aggarwal","year":"2015","unstructured":"Aggarwal R, Ringold S, Khanna D et al (2015) Distinctions between diagnostic and classification criteria? Arthritis Care Res (Hoboken) 67:891\u2013897. https:\/\/doi.org\/10.1002\/acr.22583","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"7108_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1136\/annrheumdis-2019-216155","volume":"79","author":"C Adamichou","year":"2020","unstructured":"Adamichou C, Nikolopoulos D, Genitsaridi I et al (2020) In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR\/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment. Ann Rheum Dis 79:232\u2013241. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216155","journal-title":"Ann Rheum Dis"},{"key":"7108_CR14","doi-asserted-by":"publisher","first-page":"1023451","DOI":"10.3389\/fimmu.2022.1023451","volume":"13","author":"W Lu","year":"2022","unstructured":"Lu W, Tian F, Ma J et al (2022) Diagnostic accuracy of the European League against rheumatism\/American College of Rheumatology-2019 versus the Systemic Lupus International Collaborating Clinics-2012 versus the ACR-1997 classification criteria in adult systemic lupus erythematosus: A systematic review and meta-analysis. Front Immunol 13:1023451","journal-title":"Front Immunol"},{"key":"7108_CR15","doi-asserted-by":"publisher","first-page":"e000718","DOI":"10.1136\/lupus-2022-000718","volume":"9","author":"W Lu","year":"2022","unstructured":"Lu W, Zhong Y, Weng C et al (2022) Utility of the ACR-1997, SLICC-2012 and EULAR\/ACR-2019 classification criteria for systemic lupus erythematosus: a single-centre retrospective study. Lupus Sci Med 9:e000718. https:\/\/doi.org\/10.1136\/lupus-2022-000718","journal-title":"Lupus Sci Med"},{"key":"7108_CR16","doi-asserted-by":"publisher","first-page":"100133","DOI":"10.1016\/j.jtauto.2021.100133","volume":"4","author":"D Guavita-Navarro","year":"2021","unstructured":"Guavita-Navarro D, Gallego-Cardona L, Arredondo AM et al (2021) Comparison of the sensitivity of the EULAR \/ ACR 2019 and SLICC 2012 classification criteria in a Colombian population with systemic lupus erythematosus. J Transl Autoimmun 4:100133. https:\/\/doi.org\/10.1016\/j.jtauto.2021.100133","journal-title":"J Transl Autoimmun"},{"key":"7108_CR17","doi-asserted-by":"publisher","first-page":"151932","DOI":"10.1016\/j.semarthrit.2021.12.004","volume":"52","author":"MH Lee","year":"2022","unstructured":"Lee MH, Koh JWH, Ng CH et al (2022) A meta-analysis of clinical manifestations in asian systemic lupus erythematous: The effects of ancestry, ethnicity and gender. Semin Arthritis Rheum 52:151932. https:\/\/doi.org\/10.1016\/j.semarthrit.2021.12.004","journal-title":"Semin Arthritis Rheum"},{"key":"7108_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1177\/096120339500400106","volume":"4","author":"P Zufferey","year":"1995","unstructured":"Zufferey P, Meyer OC, Bourgeois P et al (1995) Primary systemic Sj\u00f6gren syndrome (SS) preceding systemic lupus erythematosus: a retrospective study of 4 cases in a cohort of 55 SS patients. Lupus 4:23\u201327. https:\/\/doi.org\/10.1177\/096120339500400106","journal-title":"Lupus"},{"key":"7108_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF01451046","volume":"17","author":"MG Danieli","year":"1998","unstructured":"Danieli MG, Fraticelli P, Salvi A et al (1998) Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. Clin Rheumatol 17:195\u2013201. https:\/\/doi.org\/10.1007\/BF01451046","journal-title":"Clin Rheumatol"},{"key":"7108_CR20","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1093\/rheumatology\/keac005","volume":"61","author":"A Erden","year":"2022","unstructured":"Erden A, Apayd\u0131n H, Fanouriakis A et al (2022) Performance of the systemic lupus erythematosus risk probability index in a cohort of undifferentiated connective tissue disease. Rheumatology (Oxford) 61:3606\u20133613. https:\/\/doi.org\/10.1093\/rheumatology\/keac005","journal-title":"Rheumatology (Oxford)"},{"key":"7108_CR21","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s10067-024-06893-9","volume":"43","author":"L Zhang","year":"2024","unstructured":"Zhang L, Ma J, Yan D et al (2024) Classifying systemic lupus erythematosus using laboratory items alone: a preliminary study. Clin Rheumatol 43:1037\u20131043. https:\/\/doi.org\/10.1007\/s10067-024-06893-9","journal-title":"Clin Rheumatol"},{"key":"7108_CR22","doi-asserted-by":"crossref","unstructured":"Adamichou C, Bertsias G (2023) Response to: \u2019Correspondence on \u201cLupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus\u201d by Batu et al. Ann Rheum Dis 82:e145","DOI":"10.1136\/annrheumdis-2021-220262"},{"key":"7108_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220246","volume":"82","author":"ED Batu","year":"2023","unstructured":"Batu ED, Kaya Akca U, Basaran O et al (2023) Correspondence on \u201cLupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine-learning-based model to assist the diagnosis of systemic lupus erythematosus.\u201d Ann Rheum Dis 82:e144","journal-title":"Ann Rheum Dis"},{"key":"7108_CR24","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3899\/jrheum.200871","volume":"48","author":"ED Batu","year":"2021","unstructured":"Batu ED, Akca UK, K\u0131saarslan AP et al (2021) The performances of the ACR 1997, SLICC 2012, and EULAR\/ACR 2019 classification criteria in pediatric systemic lupus erythematosus. J Rheumatol 48:907\u2013914. https:\/\/doi.org\/10.3899\/jrheum.200871","journal-title":"J Rheumatol"},{"key":"7108_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.amjmed.2021.07.015","volume":"135","author":"N Kapsala","year":"2022","unstructured":"Kapsala N, Nikolopoulos D, Flouda S et al (2022) First diagnosis of systemic lupus erythematosus in hospitalized patients: clinical phenotypes and pitfalls for the non-specialist. Am J Med 135:244-253.e3. https:\/\/doi.org\/10.1016\/j.amjmed.2021.07.015","journal-title":"Am J Med"},{"key":"7108_CR26","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/art.37795","volume":"65","author":"CH Feldman","year":"2013","unstructured":"Feldman CH, Hiraki LT, Liu J et al (2013) Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000\u20132004. Arthritis Rheum 65:753\u2013763. https:\/\/doi.org\/10.1002\/art.37795","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07108-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07108-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07108-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T20:32:13Z","timestamp":1729283533000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07108-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,7]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["7108"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07108-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,7]]},"assertion":[{"value":"2 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study design was approved by the institutional review board of Universidad del Rosario. Classified as minimal risk according to Resolution 8430 of 1993 from the Ministry of Health of Colombia, the study adhered to the principles outlined in the Declaration of Helsinki and followed Good Clinical Practice guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None of the patients were required to consent to publish, given the study's retrospective nature.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}